GlassScriptPhysician profile
Debra C Placek
NPI 1407822174
$2,539.58
in general payments reported to CMS, 2019-2025
28 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $113 · 2021: $321 · 2022: $389 · 2023: $467 · 2024: $625 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,464.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $531.84 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $452.37 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $154.39 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.04 | 2019-2025 | |
| Organon LLC | $119.66 | 2022-2024 | Nexplanon |
| Exeltis, USA INC. | $109.68 | 2022-2025 | Slynd |
| Meditrina | $107.25 | 2021 | |
| Biogen, INC. | $105.69 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $101.66 | 2023-2024 | Myfembree |
| Conmed Corporation | $79.52 | 2024 | |
| Hologic Sales and Service, LLC | $73.26 | 2024-2025 | Acessa Provu System, Omni Hysteroscope, Novasure |
| Pfizer INC. | $70.81 | 2022-2023 | |
| Coopersurgical, INC. | $69.40 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Merck Sharp & Dohme LLC | $56.41 | 2019-2022 | |
| Myovant Sciences INC. | $55.79 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $49.40 | 2019-2023 | Injectafer |
| Coloplast Corp | $44.64 | 2021 | |
| Boston Scientific Corporation | $31.71 | 2019-2024 | Advantage System |
| Ethicon US, LLC | $29.26 | 2021 | |
| Allergan, INC. | $26.11 | 2019 | |
| Therapeuticsmd, INC. | $23.79 | 2019-2020 | |
| Myriad Women'S Health, INC. | $21.20 | 2023 | Myrisk |
| Baxter Healthcare | $20.97 | 2022 | |
| Covidien LP | $13.81 | 2019 | |
| Exact Sciences Corporation | $13.11 | 2023 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $13.03 | 2022 | |
| Lilly USA, LLC | $11.86 | 2021 | |
| Duchesnay USA Incorporated | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Placek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.